Biphenotypic Primary Liver Carcinomas: Assessing Outcomes of Hepatic Directed Therapy

被引:0
作者
Kathryn Fowler
Nael E. Saad
Elizabeth Brunt
M. B. Majella Doyle
Manik Amin
Neeta Vachharajani
Benjamin Tan
William C. Chapman
机构
[1] Washington University,Department of Radiology
[2] Washington University,Department of Immunology and Pathology
[3] Washington University,Department of Surgery
[4] Washington University,Department of Internal Medicine and Oncology
来源
Annals of Surgical Oncology | 2015年 / 22卷
关键词
Overall Survival; Gemcitabine; Sorafenib; Tace; Systemic Chemotherapy;
D O I
暂无
中图分类号
学科分类号
摘要
引用
收藏
页码:4130 / 4137
页数:7
相关论文
共 205 条
  • [1] Akiba J(2004)Appropriate body-mass index for Asian populations and its implications for policy and intervention strategies Lancet 363 157-163
  • [2] Nakashima O(2013)Clinicopathologic analysis of combined hepatocellular-cholangiocarcinoma according to the latest WHO classification Am J Surg Pathol 37 496-505
  • [3] Hattori S(2013)Clinicopathologic significance of combined hepatocellular-cholangiocarcinoma with stem cell subtype components with reference to the expression of putative stem cell markers Am J Clin Pathol 140 329-340
  • [4] Tanikawa K(2014)Clinicopathological significance of “subtypes with stem-cell feature” in combined hepatocellular-cholangiocarcinoma Liver Int 35 1024-1035
  • [5] Takenaka M(2015)Biphenotypic (hepatobiliary) primary liver carcinomas: the work in progress Hepat Oncol 2 255-273
  • [6] Nakayama M(2006)Comparison of combined hepatocellular and cholangiocarcinoma with hepatocellular carcinoma and intrahepatic cholangiocarcinoma Surg Today 36 892-897
  • [7] Ikeda H(2002)Combined hepatocellular and cholangiocarcinoma: demographic, clinical, and prognostic factors Cancer 94 2040-2046
  • [8] Harada K(1949)Combined liver cell and bile duct carcinoma Am J Pathol 25 647-655
  • [9] Sato Y(2002)Comparing combined hepatocellular-cholangiocarcinoma and cholangiocarcinoma: a clinicopathological study Hepatogastroenterology 49 1487-1490
  • [10] Sasaki M(2003)Combined hepatocellular and cholangiocarcinoma: a clinicopathologic study of 26 resected cases Jpn J Clin Oncol 33 283-287